Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Broad bacterial surface structures encompass a diverse array of molecular components that form the outer boundary of bacterial cells, including the cell wall, plasma membrane, and external appendages like flagella and pili. These structures are essential for maintaining cellular integrity, mediating environmental interactions, and facilitating pathogenesis through adhesion and immune evasion (Silhavy et al., 2010, Cold Spring Harb Perspect Biol; Brown et al., 2015, Nat Rev Microbiol). In Gram-negative bacteria, the outer membrane is characterized by lipopolysaccharides (LPS), while Gram-positive bacteria possess a thick layer of peptidoglycan and teichoic acids (Swoboda et al., 2010, ChemBioChem). These components serve as primary targets for numerous classes of antibiotics; for instance, beta-lactams inhibit peptidoglycan cross-linking, and polymyxins disrupt the outer membrane (Kohanski et al., 2010, Nat Rev Microbiol). Furthermore, these structures act as Pathogen-Associated Molecular Patterns (PAMPs) that are recognized by the host's innate immune system via Pattern Recognition Receptors (PRRs), triggering inflammatory responses (Mogensen, 2009, Clin Microbiol Rev). Targeting these broad structures is a cornerstone of antimicrobial therapy, though it faces challenges such as the development of multi-drug resistance and the potential for systemic toxicity from the release of bacterial toxins during treatment (Wright, 2011, Chem Commun).
Inhibition of peptidoglycan cell wall synthesis, disruption of the bacterial cytoplasmic or outer membrane, and neutralization of surface-associated toxins or inflammatory mediators.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Broad bacterial surface structures.